No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1054 |
4. Check minimum number of eventsNone |
1054 |
5. Include endpointsNone |
1054 |
6. Filter based on genotype QC (FinnGen only) |
1005 |
Control definitions (FinnGen only)
- Control exclude
- IBD_BACT_INTEST_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- A04
- Name in latin
- Enteritis campylobacterialis
Similar endpoints
↥List of similar endpoints to
Campylobacter enteritis
based on the number of shared cases.
Similar with more cases:
- Bacterial intestinal infections, IBD co-morbidities
- Infections, IBD-co-morbidities
- Intestinal infectious diseases
- Intestinal infectious diseases
- Certain infectious and parasitic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6934 | 3062 | 3832 |
| Only index persons | 6408 | 2845 | 3563 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.09 | 0.11 |
| Only index persons | 0.12 | 0.10 | 0.14 |
| Median age at first event (years) | |||
| Whole population | 46.13 | 46.05 | 46.04 |
| Only index persons | 44.90 | 44.55 | 45.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1005 | 510 | 495 |
| Unadjusted period prevalence (%) | 0.20 | 0.18 | 0.23 |
| Median age at first event (years) | 51.51 | 47.52 | 55.63 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1054
- Matched controls
- 10540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
11.1
307.7
606
1141
A04.5
ICD-10 Finland
Campylobacter enteritis
9630.7
307.7
966
12
J01MA02
ATC
ciprofloxacin; systemic
3.6
91.1
590
2758
0084E
ICD-9 Finland
Intestinal infections due to other organisms, Other specified bacteria[ENTERITIS CAMPYLOBACTER]
+∞
91.0
86
*
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
171.1
47.2
49
*
R50.9
ICD-10 Finland
Fever, unspecified
3.1
46.6
235
889
J01FA06
ATC
roxithromycin; oral
2.4
43.3
508
2914
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
37.6
537
3291
J01FA10
ATC
azithromycin; systemic
2.3
34.5
674
4633
H02AB06
ATC
prednisolone; systemic
2.1
31.9
550
3557
D11
ICPC
Diarrhoea
2.8
30.9
173
683
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
46.5
29.8
36
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
28.9
176
725
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
28.5
423
2554
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
24.1
143
578
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
23.4
150
630
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
23.2
318
1838
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.7
22.4
129
513
H02AB04
ATC
methylprednisolone; systemic
2.4
21.6
177
832
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.9
20.8
62
165
P01AB01
ATC
metronidazole; oral, rectal
1.9
20.6
438
2910
A02BC02
ATC
pantoprazole; systemic
1.9
20.2
714
5541
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
18.2
536
3886
UJF32
NOMESCO Finland
Coloscopy
1.9
18.1
277
1642
127
Kela drug reimbursment
Transplant complication
6.0
17.5
31
53
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.9
16.8
50
133
L04AX01
ATC
azathioprine; systemic
3.5
16.8
59
176
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
16.4
249
1466
UJF30
NOMESCO Finland
Ileoscopy through colon
2.4
16.0
118
527
J01DB01
ATC
cefalexin; oral
2.0
15.9
871
7435
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.0
15.9
185
994
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
14.9
270
1676
J01FA01
ATC
erythromycin; systemic
2.1
14.8
156
805
A02BC05
ATC
esomeprazole; systemic
1.7
14.7
417
2938
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
14.7
235
1404
H02AB09
ATC
hydrocortisone; systemic
4.4
14.1
35
81
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
14.1
169
915
H02AB07
ATC
prednisone; oral
2.1
13.8
149
775
A02BC03
ATC
lansoprazole; oral
1.7
13.6
294
1915
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
3.3
13.6
52
164
N02AX02
ATC
tramadol; systemic, rectal
1.6
13.1
441
3221
R51.80
ICD-10 Finland
Headache
1.9
13.1
175
982
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
12.9
201
1187
J01FF01
ATC
clindamycin; systemic
1.7
12.8
283
1851
R03AC02
ATC
salbutamol; inhalant
1.6
12.7
571
4463
A02BC01
ATC
omeprazole; systemic
1.7
12.7
275
1788
L04AA06
ATC
mycophenolic acid; systemic
4.7
12.6
29
63
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
12.6
49
156
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.9
12.1
58
209
M25.5
ICD-10 Finland
Pain in joint
1.7
12.1
331
2286
R01AD09
ATC
mometasone; nasal
1.6
12.0
467
3512
J01AA02
ATC
doxycycline; systemic
1.7
12.0
786
6693
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.6
12.0
69
274
J01DA01
ATC
[U] cefalexin
1.6
11.9
633
5115
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.6
11.9
455
3407
A07EA06
ATC
budesonide; oral, local oral
3.1
11.9
49
162
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.3
11.8
30
71
M02.1
ICD-10 Finland
Postdysenteric arthropathy
30.4
11.7
15
5
D01
ICPC
Abdominal pain/cramps general
2.1
11.7
124
641
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
11.6
221
1383
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.5
261
1711
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
11.5
127
665
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
11.5
117
595
N03AX16
ATC
[U] pregabalin
1.7
11.3
234
1497
R06.0
ICD-10 Finland
Dyspnoea
1.7
11.2
268
1781
N02BE01
ATC
paracetamol; systemic, rectal
1.9
11.2
911
8138
R06AE07
ATC
cetirizine; oral
1.6
11.0
435
3264
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
10.9
299
2055
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.9
226
1445
A07EC02
ATC
mesalazine; oral, rectal
2.5
10.9
68
281
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
10.7
101
498
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
10.7
240
1565
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
10.6
428
3218
Z94.0
ICD-10 Finland
Kidney transplant status
8.1
10.6
23
29
M04AA01
ATC
allopurinol; systemic
2.0
10.5
125
673
M01AH01
ATC
celecoxib; oral
1.8
10.5
174
1043
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
10.5
46
158
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
10.4
78
350
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
10.4
372
2719
J01CA04
ATC
amoxicillin; systemic
1.7
10.4
836
7330
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.0
10.4
29
74
R4110
NOMESCO Finland
Physiotherapy
1.6
10.3
268
1814
AA1AD
NOMESCO Finland
CT of head and brain
1.7
10.3
256
1713
M10.9
ICD-10 Finland
Gout, unspecified
2.4
10.3
71
307
C10AA05
ATC
atorvastatin; oral
1.6
10.1
375
2760
J01FA09
ATC
clarithromycin; systemic
1.6
10.1
315
2229
ZXE00
NOMESCO Finland
One hour or less
1.6
10.1
379
2799
Z3226
NOMESCO Finland
Physiotherapist
1.8
10.1
180
1102
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
3.2
10.0
39
125
B03XA02
ATC
darbepoetin alfa; parenteral
4.0
9.9
28
72
A03
ICPC
Fever
1.8
9.9
174
1060
R60.0
ICD-10 Finland
Localized oedema
2.0
9.8
112
593
M03BX02
ATC
tizanidine; oral
1.5
9.8
628
5185
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
9.8
98
495
ZXD05
NOMESCO Finland
Urgent procedure
1.6
9.8
307
2173
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
9.6
179
1108
A02.0
ICD-10 Finland
Salmonella enteritis
10.2
9.5
18
18
K59.1
ICD-10 Finland
Functional diarrhoea
2.5
9.5
59
243
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.5
211
1369
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.6
9.5
57
231
N06AX11
ATC
mirtazapine; oral
1.6
9.5
331
2397
J01MA12
ATC
levofloxacin; systemic
1.7
9.4
176
1089
ZX120
NOMESCO Finland
Intravenous
2.0
9.3
98
505
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.1
9.2
90
451
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.3
9.2
23
54
E0000UV, ,
ATC
1.5
9.1
395
2992
L04AA01
ATC
[U] ciclosporin
5.1
9.1
19
38
E66.8
ICD-10 Finland
Other obesity
2.4
9.1
62
267
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.1
240
1627
M79.6
ICD-10 Finland
Pain in limb
1.5
9.1
400
3041
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
9.0
185
1175
L04AD01
ATC
ciclosporin; systemic
3.9
9.0
26
68
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
8.9
42
150
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
8.9
266
1857
J02AC01
ATC
fluconazole; systemic
1.5
8.8
367
2751
WX892
NOMESCO Finland
Monitored bed care
2.1
8.8
79
383
R10.0
ICD-10 Finland
Acute abdomen
3.0
8.7
38
130
A04.0
ICD-10 Finland
Enteropathogenic Escherichia coli infection
50.4
8.7
10
*
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
8.3
8.6
18
22
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.3
8.6
64
287
M01AH05
ATC
etoricoxib; oral
1.5
8.6
614
5122
C03CA01
ATC
furosemide; systemic
1.6
8.5
252
1750
A11CC03
ATC
alfacalcidol; systemic
3.5
8.5
29
85
Z3231
NOMESCO Finland
Registered nurse
1.6
8.5
261
1829
Z71.8
ICD-10 Finland
Other specified counselling
1.5
8.5
297
2144
A11
ICPC
Chest pain NOS
2.1
8.4
80
396
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.9
8.4
38
133
M01AE02
ATC
naproxen; oral, rectal
1.5
8.3
561
4612
J01MA14
ATC
moxifloxacin; systemic
2.0
8.3
91
476
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.3
8.3
31
97
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
8.3
197
1299
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
1.9
8.2
111
622
D07AC01
ATC
betamethasone; topical
1.5
8.2
341
2548
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.2
706
6079
K51.5
ICD-10 Finland
Left sided colitis
3.0
8.2
36
124
T78.4
ICD-10 Finland
Allergy, unspecified
2.6
8.2
48
193
Z2221
NOMESCO Finland
Medical doctor
1.5
8.2
265
1879
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
8.1
54
230
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.8
8.1
18
38
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
8.1
338
2528
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
8.0
378
2895
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
8.0
255
1801
A12AA04
ATC
calcium carbonate; oral
4.3
8.0
20
47
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
7.9
74
364
UJF92
NOMESCO Finland
Capsular endoscopy
3.8
7.9
24
65
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
7.9
89
470
SPAT1263
SPAT
Sampling
1.5
7.8
391
3025
L03
ICPC
Low back symptom/complaint
1.5
7.7
258
1837
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
7.6
541
4463
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
7.6
186
1232
R03BA01
ATC
beclometasone; inhalant
1.7
7.6
134
814
M01AB05
ATC
diclofenac; systemic, rectal
1.4
7.6
655
5598
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
7.6
216
1484
A04.8
ICD-10 Finland
Other specified bacterial intestinal infections
11.9
7.6
13
11
G44.8
ICD-10 Finland
Other specified headache syndromes
4.1
7.6
20
49
R06AE09
ATC
levocetirizine; oral
1.7
7.5
143
888
R05
ICPC
Cough
1.6
7.4
223
1552
J01MA01
ATC
ofloxacin; systemic
2.0
7.4
85
452
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
7.4
510
4178
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
7.4
235
1655
S06.0
ICD-10 Finland
Concussion
1.8
7.4
109
629
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.3
116
683
WX002
NOMESCO Finland
Sedation and analgesia
1.6
7.3
176
1161
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
9.4
7.3
14
15
R74
ICPC
Upper respiratory infection acute
1.5
7.3
312
2336
G44.2
ICD-10 Finland
Tension-type headache
1.7
7.3
135
832
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.4
7.3
47
198
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.0
7.3
31
105
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
7.3
59
275
K03.00
ICD-10 Finland
Approximal wear
2.0
7.3
79
412
A28
ICPC
Limited function/disability NOS
1.7
7.2
137
850
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
4.0
7.2
20
51
H57.1
ICD-10 Finland
Ocular pain
2.5
7.2
44
181
S18
ICPC
Laceration/cut
1.4
7.2
420
3335
M54.5
ICD-10 Finland
Low back pain
1.5
7.1
343
2624
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
6.6
7.1
17
26
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
7.1
128
782
R06AX27
ATC
desloratadine; oral
1.5
7.1
275
2016
SPAT1104
SPAT
Monitoring of emergency patient
2.2
7.1
60
285
B01AB05
ATC
enoxaparin; parenteral
1.5
7.0
281
2073
R03BA02
ATC
budesonide; inhalant
1.6
7.0
173
1147
TK800
NOMESCO Finland
Hemodialysis
3.3
7.0
25
76
N05CF01
ATC
zopiclone; oral
1.5
7.0
289
2147
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
7.0
223
1570
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
6.9
85
462
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.6
6.9
202
1394
C01CA24
ATC
epinephrine; parenteral
2.0
6.9
70
356
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.2
6.9
54
248
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
6.9
123
751
ZXA05
NOMESCO Finland
Left side
1.5
6.8
216
1516
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
8.3
6.8
14
17
A07AA02
ATC
nystatin; oral
2.2
6.8
53
243
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
6.8
150
969
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
6.8
275
2034
K51.8
ICD-10 Finland
Other ulcerative colitis
3.5
6.7
22
63
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.8
6.7
107
632
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
6.6
263
1934
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.9
6.6
78
418
D07AC13
ATC
mometasone; topical
1.5
6.6
265
1955
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.0
6.5
69
356
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
6.5
238
1720
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.8
6.5
96
553
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
6.5
53
248
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
2.3
6.5
46
203
C07AB07
ATC
bisoprolol; oral
1.4
6.4
428
3459
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
6.4
133
845
B01AB04
ATC
dalteparin; parenteral
2.3
6.4
48
217
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.3
338
2625
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
6.3
182
1250
WX402
NOMESCO Finland
General anaesthesia
1.5
6.3
197
1377
A07EC01
ATC
sulfasalazine; oral, rectal
1.9
6.3
80
440
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
6.3
147
961
X57
ICD-10 Finland
Unspecified privation
3.0
6.3
27
92
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.4
6.3
295
2238
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.3
296
2248
M22.4
ICD-10 Finland
Chondromalacia patellae
2.7
6.3
33
126
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
6.3
163
1094
J01MA06
ATC
norfloxacin; oral
1.7
6.2
117
724
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.0
6.2
17
43
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
5.4
6.2
17
32
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
2.2
6.2
51
240
EB1SA, ,
SPAT
2.1
6.1
58
288
K03.28
ICD-10 Finland
Other erosion of teeth
3.1
6.1
25
83
Z2446
NOMESCO Finland
Social worker
2.0
6.1
68
359
L04AD02
ATC
tacrolimus; systemic
5.2
6.0
17
33
N18.8
ICD-10 Finland
Other chronic renal failure
3.4
6.0
21
63
R03AC03
ATC
terbutaline; inhalant
1.6
6.0
130
834
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
317
527
8.17
194.60
1.6
1.5
—
—
—
0
0
155
196
9.10
117.47
1.3
1.2
—
—
—
0
0
110
171
7.07
68.89
1.8
1.3
—
—
—
0
0
679
4282
2.65
49.19
7.2
6.3
10.81
11.57
umol/l
1.06
649
4076
64
101
6.68
39.22
2.0
1.4
—
—
—
0
0
64
103
6.55
38.49
2.0
1.4
—
—
—
0
0
64
103
6.55
38.49
2.0
1.4
—
—
—
0
0
63
100
6.64
38.39
2.0
1.4
—
—
—
0
0
63
100
6.64
38.39
2.0
1.4
—
—
—
0
0
456
2598
2.33
38.17
2.9
2.5
51.38
91.07
u/l
0.71
426
2431
63
101
6.57
38.02
2.0
1.4
—
—
—
0
0
852
6385
2.74
37.42
10.5
7.4
75.69
77.90
u/l
0.95
822
6038
100
256
4.21
35.52
1.3
1.1
—
—
—
0
0
102
267
4.12
35.16
2.2
1.7
—
—
—
0
0
694
4831
2.28
34.41
11.6
9.0
4.21
4.12
e9/l
0.42
622
4231
98
255
4.13
34.04
1.3
1.1
—
—
—
0
0
39
41
9.84
33.44
1.2
1.2
—
—
—
0
0
267
1269
2.48
32.92
2.1
1.8
—
—
—
0
0
608
4070
2.17
32.45
8.2
6.0
27.84
27.91
%
0.04
585
3827
38
41
9.58
31.96
1.2
1.2
—
—
—
0
0
187
759
2.78
31.72
2.9
2.4
105.51
39.77
u/l
0.48
171
655
600
4021
2.14
31.60
7.9
5.7
57.47
57.24
%
0.18
577
3785
527
3400
2.10
30.23
7.0
4.8
35.18
35.88
g/l
2.10
498
3177
679
4838
2.13
29.61
6.2
4.8
6.73
6.66
mmol/l
0.34
644
4534
460
2883
2.06
27.88
4.2
3.1
—
—
—
0
0
404
2428
2.08
27.33
3.9
3.1
27.60
101.09
e6/l
1.83
308
1865
725
5412
2.09
26.38
5.1
4.1
1911.00
2083.93
e6/l
0.03
11
80
193
875
2.48
25.80
2.0
1.7
—
—
—
0
0
31
34
9.36
25.71
1.2
1.2
—
—
—
0
0
31
34
9.36
25.71
1.2
1.2
—
—
—
0
0
372
2211
2.05
25.58
3.7
3.0
0.41
0.46
e6/l
0.13
280
1676
528
3552
1.97
25.49
8.3
6.1
1.20
1.21
mmol/l
2.08
491
3248
169
727
2.58
25.20
4.7
3.7
1.14
1.92
mmol/l
1.90
137
599
212
1016
2.36
24.99
3.0
2.4
316.71
118.28
ug/g
3.91
184
813
168
732
2.54
24.35
4.8
3.7
5.70
5.84
kpa
1.14
162
713
191
886
2.41
24.17
2.0
1.8
—
—
—
0
0
470
3102
1.93
23.39
4.0
3.4
41.32
40.21
ng/l
0.05
324
2047
252
1333
2.17
23.26
3.0
2.7
1.06
1.00
e6/l
0.13
140
761
987
8565
3.40
22.90
22.1
13.1
33.87
23.52
mg/l
13.37
900
6765
784
6164
2.06
22.87
5.2
4.0
12.84
11.31
mm/h
1.92
736
5723
577
4108
1.89
22.44
4.1
3.3
0.00
0.00
estimate
0.50
96
803
532
3696
1.89
22.27
15.7
13.3
1.23
1.24
inr
0.04
152
1104
557
3928
1.89
22.24
9.7
6.8
1.21
1.21
mmol/l
1.50
491
3362
578
4142
1.88
21.77
4.1
3.4
0.00
0.00
estimate
0.50
89
733
571
4094
1.86
21.29
5.7
4.6
0.00
0.00
estimate
0.50
94
766
117
468
2.69
20.04
1.5
1.3
—
—
—
0
0
233
1260
2.09
19.99
3.5
2.9
2.40
2.10
e6/l
0.25
124
694
735
5795
1.89
19.35
3.6
3.1
—
—
—
0
0
202
1050
2.14
19.15
3.2
2.5
22.37
23.65
%
0.61
175
902
334
2085
1.88
18.77
5.8
3.8
93.99
91.52
%
1.07
329
2035
139
624
2.41
18.68
3.8
3.0
4.92
4.63
kpa
0.54
134
603
983
8699
2.93
18.28
24.0
14.8
139.32
139.65
mmol/l
4.56
968
8480
984
8723
2.93
18.03
24.4
14.9
3.93
3.97
mmol/l
4.28
969
8485
209
1126
2.07
17.94
3.2
2.4
2.29
2.34
g/l
0.68
197
1046
261
1537
1.93
17.33
4.5
3.7
461.43
485.07
ng/l
0.03
187
1145
220
1224
2.01
17.22
3.2
2.4
12.81
13.75
umol/l
1.22
207
1146
59
173
3.55
17.21
6.7
5.6
232.00
351.10
iu/ml
0.31
11
21
50
131
3.96
17.14
1.1
1.1
—
—
—
0
0
192
1023
2.07
16.90
9.6
5.7
1.04
1.02
mmol/l
0.35
184
946
313
1978
1.83
16.56
2.5
2.1
3.20
2.94
mg/l
0.77
267
1687
166
843
2.15
16.55
4.9
4.4
226.58
261.80
u/l
1.90
161
803
184
977
2.07
16.31
3.7
2.8
6.71
9.09
umol/l
1.71
158
868
228
1312
1.94
16.09
4.5
3.5
0.80
0.82
mmol/l
1.74
217
1236
109
472
2.46
15.78
1.5
1.4
—
—
—
0
0
297
1888
1.80
15.20
1.9
1.7
0.93
1.10
mg/l
0.86
236
1421
407
2854
1.69
14.58
4.2
3.3
34.07
32.79
u/l
0.18
397
2725
266
1659
1.81
14.40
3.0
2.5
7.40
5.74
e6/l
0.80
247
1497
355
2426
1.70
13.84
2.4
2.1
242.92
256.30
u/l
0.07
335
2295
496
3696
1.65
13.84
3.8
2.7
133.18
124.89
ug/l
0.32
470
3426
79
322
2.57
12.98
2.1
2.0
1.59
1.50
g/l
0.25
73
279
30
66
4.65
12.88
1.8
1.3
—
—
—
0
0
30
66
4.65
12.88
1.8
1.3
—
—
—
0
0
101
464
2.30
12.78
1.8
1.6
—
—
—
0
0
763
6414
1.69
12.61
4.4
3.8
14.55
14.68
pmol/l
0.73
707
5884
449
3324
1.61
12.46
2.7
2.3
78.01
75.98
nmol/l
0.75
414
2999
153
841
1.96
12.12
3.1
2.8
1.83
1.76
%
0.32
136
758
311
2112
1.67
12.12
3.4
2.7
4132.55
7121.08
umol/l
0.56
282
1878
856
7490
1.76
11.47
23.9
15.7
14.78
14.76
%
0.02
848
7366
129
685
2.01
11.26
10.9
7.5
10.59
9.14
mmol/l
1.39
120
651
991
9132
2.43
11.03
14.6
9.8
28.15
27.34
u/l
0.68
972
8859
426
3186
1.57
10.91
2.3
1.9
94.81
94.95
pmol/l
0.02
256
1696
307
2143
1.61
10.47
3.3
3.1
1750.54
1286.31
ng/l
1.08
259
1806
875
7765
1.75
10.39
5.3
4.5
1.82
2.02
mu/l
0.71
821
7165
31
83
3.82
10.36
1.3
1.3
—
—
—
0
0
199
1251
1.73
10.13
2.1
2.2
29.98
29.70
s
0.24
192
1213
133
742
1.91
10.03
2.9
2.4
0.22
0.22
g/l
0.40
124
703
268
1841
1.61
9.65
1.8
1.5
19.44
20.30
nmol/l
0.51
235
1574
119
648
1.94
9.64
3.7
2.6
10.08
10.48
g/l
0.53
103
597
896
8062
1.74
9.40
18.8
11.9
83.06
83.87
ml/min/173m2
0.46
768
6638
151
895
1.80
9.38
7.6
8.8
1.02
1.12
mmol/l
0.12
115
714
270
1891
1.58
8.87
1.3
1.2
0.80
1.47
u/ml
1.68
78
525
212
1404
1.64
8.77
3.4
3.0
2.44
2.44
mmol/l
0.00
186
1245
355
2660
1.50
8.50
3.9
3.3
2.33
2.35
mmol/l
1.92
316
2363
42
156
2.76
8.33
1.4
1.3
—
—
—
0
0
42
156
2.76
8.33
1.4
1.3
—
—
—
0
0
47
186
2.60
8.25
2.1
1.7
—
—
—
0
0
147
899
1.74
8.17
7.8
8.8
5.10
5.15
kpa
0.24
140
862
688
5898
1.48
8.15
4.1
3.1
55.88
48.70
u/l
1.43
650
5580
54
230
2.42
8.14
1.5
1.4
245.65
285.00
ug/g
0.58
24
131
147
900
1.74
8.14
7.8
8.7
12.10
12.35
kpa
0.22
138
866
26
74
3.58
8.01
2.6
2.5
—
—
—
0
0
492
3968
1.45
7.96
3.0
2.5
—
—
—
0
0
39
146
2.74
7.64
2.3
2.2
17.11
16.39
%
0.35
19
76
238
1672
1.55
7.57
1.6
1.4
2.44
2.43
g/l
0.03
165
1061
201
1360
1.59
7.53
1.9
1.7
1296.94
1162.95
nmol/l
1.40
163
1036
859
7765
1.57
7.45
6.5
5.4
39.69
39.50
mmol/mol
0.24
808
7264
276
2014
1.50
7.33
2.8
2.2
—
—
—
0
0
88
475
1.93
7.32
4.3
3.5
1.74
1.70
mmol/l
0.02
61
355
408
3215
1.44
7.29
4.3
3.4
—
—
—
0
0
51
227
2.31
7.00
5.1
4.0
1.65
1.49
mg/l
0.70
51
207
301
2269
1.46
6.70
3.9
3.2
875.22
290.16
mg/l
0.82
199
1481
200
1388
1.54
6.66
1.3
1.3
6.85
10.32
u/ml
0.42
79
562
35
134
2.67
6.60
2.4
1.8
—
—
—
0
0
1011
9622
2.24
6.56
31.7
19.2
250.28
250.41
e9/l
0.02
1002
9401
43
184
2.39
6.46
2.3
1.7
—
—
—
0
0
325
2501
1.43
6.44
3.9
3.2
7.97
8.00
mmol/l
0.03
285
2117
1011
9629
2.22
6.43
31.6
19.2
4.47
4.54
e12/l
3.69
1003
9388
1011
9630
2.22
6.41
31.7
19.2
6.84
6.78
e9/l
0.23
1003
9382
57
276
2.13
6.41
1.4
1.3
—
—
—
0
0
102
609
1.75
6.16
2.4
2.8
65.20
66.87
g/l
1.35
91
554
110
673
1.71
6.09
2.6
2.3
5.08
7.77
ug/l
1.20
97
602
34
135
2.57
5.99
1.7
1.7
—
—
—
0
0
34
135
2.57
5.99
1.7
1.7
—
—
—
0
0
1008
9615
2.11
5.96
32.1
19.3
39.77
40.52
%
3.38
960
9036
34
136
2.55
5.91
1.9
1.6
—
—
—
0
0
287
2189
1.43
5.89
4.5
3.6
0.00
0.01
estimate
1.08
86
744
224
1632
1.47
5.86
1.9
1.5
—
—
—
0
0
310
2403
1.41
5.79
4.7
3.8
13.68
9.16
mg/mmol
0.81
201
1530
31
121
2.61
5.67
1.9
1.6
—
—
—
0
0
55
276
2.05
5.66
1.5
1.3
9.66
9.36
u/l
0.05
38
224
105
650
1.68
5.58
3.6
2.7
62.65
69.80
ml/min/173m2
0.94
46
265
28
105
2.71
5.53
1.9
1.6
—
—
—
0
0
22
72
3.10
5.51
3.8
2.4
—
—
—
0
0
15
29
5.23
5.40
1.8
1.2
—
—
—
0
0
95
579
1.70
5.35
6.8
3.9
124.09
80.61
ng/l
2.22
85
517
240
1803
1.43
5.29
4.5
3.7
1.02
1.02
kg/l
0.01
27
241
200
1458
1.46
5.17
1.3
1.3
21.90
31.84
iu/ml
0.92
66
467
37
165
2.29
5.12
1.8
2.0
133.40
130.64
g/l
0.21
25
123
27
104
2.64
5.09
2.0
1.6
—
—
—
0
0
38
174
2.23
4.96
1.5
1.6
—
—
—
0
0
14
28
5.05
4.95
1.0
1.1
—
—
—
0
0
80
476
1.74
4.92
2.1
1.8
—
—
—
0
0
98
618
1.65
4.87
2.8
3.0
222.92
202.70
ng/l
0.15
91
563
44
216
2.08
4.83
3.4
4.0
89.01
81.00
mg/l
0.06
36
179
39
183
2.17
4.80
1.4
1.3
280.50
251.62
u/ml
0.21
22
111
82
496
1.71
4.76
10.1
10.4
0.73
0.69
%
0.42
82
491
885
8247
1.46
4.75
5.2
4.2
5.99
5.90
mmol/l
1.20
828
7578
82
498
1.70
4.70
10.0
10.3
1.39
1.40
%
0.02
82
493
10
14
7.20
4.66
4.0
5.7
—
—
—
0
0
13
26
5.05
4.64
1.8
1.2
—
—
—
0
0
94
598
1.63
4.52
2.3
1.9
—
—
—
0
0
156
1114
1.47
4.46
2.2
2.1
—
—
—
0
0
22
82
2.72
4.44
1.2
1.0
—
—
—
0
0
119
806
1.54
4.39
3.7
3.1
—
—
—
0
0
46
239
1.97
4.36
1.4
1.7
—
—
—
0
0
57
319
1.83
4.33
2.4
1.9
—
—
—
0
0
15
38
3.99
4.31
2.4
1.9
—
—
—
0
0
39
192
2.07
4.28
1.3
1.3
—
—
—
0
0
143
1012
1.48
4.28
2.1
1.9
—
—
—
0
0
87
556
1.62
4.12
1.3
1.2
174.14
250.68
u/ml
0.57
80
514
42
216
1.98
4.11
3.5
4.0
44.15
44.02
mg/l
0.00
35
180
43
224
1.96
4.06
1.2
1.1
—
—
—
0
0
13
31
4.23
4.02
2.2
2.0
—
—
—
0
0
53
299
1.81
3.95
2.1
1.7
—
—
—
0
0
19
70
2.75
3.93
2.2
1.7
—
—
—
0
0
19
70
2.75
3.93
2.2
1.7
—
—
—
0
0
19
70
2.75
3.93
2.2
1.7
—
—
—
0
0
41
213
1.96
3.91
3.5
3.9
1.29
1.93
ratio
—
5
22
22
88
2.53
3.90
2.3
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
235
1.91
3.88
3.2
2.9
0.20
0.34
u/ml
2.69
21
124
14
38
3.72
3.80
2.5
1.9
—
—
—
0
0
15
50
3.03
3.70
1.2
1.0
—
—
—
0
0
8
12
6.71
3.67
1.4
2.4
—
—
—
0
0
14
45
3.14
3.66
2.9
1.6
—
—
—
0
0
25
110
2.30
3.64
1.1
1.2
—
—
—
0
0
18
68
2.68
3.57
3.2
3.5
57.33
55.10
%
0.15
18
61
114
802
1.47
3.53
3.2
2.1
339.26
370.65
nmol/l
0.93
106
741
11
26
4.26
3.51
5.5
2.1
—
—
—
0
0
68
427
1.63
3.49
1.4
1.3
27.98
27.52
iu/l
0.03
57
357
909
8620
1.40
3.44
5.2
4.6
2.71
2.79
mmol/l
1.84
852
8021
48
275
1.78
3.43
2.2
2.4
3.36
3.60
g/l
0.85
42
249
48
275
1.78
3.43
2.2
2.4
7.34
7.37
g/l
0.05
42
249
48
275
1.78
3.43
2.2
2.4
—
—
—
0
0
45
253
1.81
3.42
2.2
2.4
10.72
10.63
g/l
0.03
39
226
13
37
3.54
3.41
3.0
1.7
—
—
—
0
0
13
37
3.54
3.41
3.0
1.7
—
—
—
0
0
23
101
2.31
3.37
1.5
1.2
—
—
—
0
0
20
83
2.44
3.32
2.5
1.8
—
—
—
0
0
14
48
2.94
3.31
9.1
8.6
44.17
65.42
u/ml
—
6
19
209
1651
1.33
3.28
1.8
1.6
452.40
41625154.73
pmol/l
2.13
168
1391
47
273
1.76
3.22
1.7
1.6
0.13
0.28
iu/ml
—
5
53
156
1183
1.37
3.19
1.9
1.9
1.46
1.44
%
0.11
144
1057
8
15
5.37
3.19
1.3
1.0
—
—
—
0
0
11
30
3.69
3.09
2.5
2.0
—
—
—
0
0
11
30
3.69
3.09
2.5
2.0
—
—
—
0
0
45
262
1.75
3.07
2.2
2.4
2.81
3.00
g/l
0.72
39
236
41
233
1.79
3.04
3.3
4.1
3.87
3.90
mmol/l
0.11
41
228
19
81
2.37
2.99
2.5
1.9
—
—
—
0
0
40
227
1.79
2.98
1.4
1.3
—
—
—
0
0
893
8492
1.34
2.91
4.8
4.2
4.61
4.67
mmol/l
1.06
843
7952
12
38
3.18
2.85
1.3
1.4
33.90
38.72
nmol/l
0.26
12
31
271
2256
1.27
2.85
1.8
1.6
1.47
1.39
mmol/l
0.78
233
1915
887
8447
1.32
2.71
4.8
4.1
1.42
1.44
mmol/l
0.97
832
7870
41
242
1.72
2.70
2.3
2.6
2.09
1.17
g/l
0.35
35
214
10
29
3.47
2.69
1.2
1.2
—
—
—
0
0
21
99
2.14
2.66
1.3
1.2
—
—
—
0
0
100
727
1.41
2.64
2.2
2.3
12.03
13.03
nmol/l
0.58
79
658
73
501
1.49
2.61
2.6
3.4
4.30
4.62
pmol/l
2.05
62
435
17
74
2.32
2.59
1.3
1.7
—
—
—
0
0
856
8134
1.28
2.51
4.3
3.8
1.37
1.31
mmol/l
2.09
802
7542
33
189
1.77
2.43
1.2
1.4
1.92
10.82
e6/l
1.56
25
147
33
189
1.77
2.43
1.3
1.5
13.68
1100.86
e6/l
0.94
28
153
16
70
2.31
2.42
1.8
1.5
0.99
1.02
g/l
0.18
16
70
20
98
2.06
2.32
1.2
1.6
—
—
—
0
0
20
98
2.06
2.32
1.2
1.6
—
—
—
0
0
8
23
3.50
2.27
1.1
1.2
—
—
—
0
0
41
256
1.63
2.24
2.5
2.9
—
—
—
0
0
13
54
2.42
2.20
2.1
1.9
—
—
—
0
0
123
955
1.33
2.19
9.4
6.6
—
—
—
0
0
24
129
1.88
2.18
1.1
1.1
—
—
—
0
0
39
243
1.63
2.16
2.2
1.7
—
—
—
0
0
45
291
1.57
2.14
1.1
1.3
179.01
240.51
miu/ml
0.73
16
147
332
2905
1.21
2.13
4.7
4.6
1.96
2.39
ug/l
0.94
293
2614
83
609
1.39
2.12
4.2
3.6
1.22
1.23
mmol/l
0.34
73
530
32
190
1.71
2.12
1.3
1.6
6588.35
14550.31
e6/l
1.16
23
141
11
43
2.57
2.08
3.6
3.3
1018.82
1221.63
u/ml
0.13
11
43
30
176
1.73
2.07
1.1
1.4
—
—
—
0
0
55
375
1.49
2.07
1.4
2.2
36.62
38.95
u/l
0.40
50
340
50
334
1.52
2.07
5.7
6.6
1.64
1.61
%
0.05
45
317
50
334
1.52
2.07
2.0
1.6
278.04
304.98
mu/l
0.39
45
304
21
110
1.93
2.06
2.6
1.6
—
—
—
0
0
14
63
2.24
2.01
2.8
2.1
951.57
567.72
ml
—
7
36
15
70
2.16
1.99
1.0
1.1
—
—
—
0
0
79
584
1.38
1.95
2.4
2.4
22.86
22.47
au/ml
—
8
48
10
39
2.58
1.94
1.8
1.5
—
—
—
0
0
10
39
2.58
1.94
1.8
1.5
—
—
—
0
0
10
39
2.58
1.94
4.2
3.1
30357.10
37489.74
ug/l
—
10
39
27
159
1.72
1.86
1.3
1.5
—
—
—
0
0
9
34
2.66
1.86
1.0
1.4
—
—
—
0
0
102
792
1.32
1.84
3.4
4.4
3.41
26.66
ug/l
1.50
70
653
42
278
1.53
1.84
3.4
4.1
1.38
1.40
mmol/l
0.06
42
271
19
101
1.90
1.81
8.4
6.3
10.71
11.05
mg/l
0.14
19
93
12
53
2.28
1.81
1.1
1.6
—
—
—
0
0
13
60
2.18
1.78
1.0
1.3
1.51
1.54
g/l
0.16
13
60
35
224
1.58
1.78
2.3
2.4
38.10
37.48
g/l
0.33
29
198
26
154
1.71
1.77
1.3
1.8
—
—
—
0
0
14
67
2.10
1.76
1.2
1.2
—
—
—
0
0
269
2346
1.20
1.76
4.1
4.0
23.55
21.24
%
1.40
119
1069
12
54
2.24
1.74
1.0
1.4
—
—
—
0
0
12
54
2.24
1.74
3.5
1.7
—
—
—
0
0
9
36
2.51
1.74
2.0
1.6
—
1224630.00
—
0
5
59
427
1.40
1.68
1.0
1.0
—
—
—
0
0
6
19
3.17
1.66
1.8
1.6
—
—
—
0
0
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
16
83
1.94
1.65
1.1
1.2
—
—
—
0
0
5
14
3.58
1.61
1.4
1.2
—
—
—
0
0
16
84
1.92
1.60
1.3
1.2
—
—
—
0
0
6
20
3.01
1.58
2.3
2.0
—
—
—
0
0
40
276
1.47
1.49
2.5
2.3
87.83
91.68
%
0.42
40
266
7
28
2.51
1.45
1.3
1.1
0.29
0.28
g/l
—
7
23
39
270
1.46
1.43
1.2
1.4
—
—
—
0
0
37
255
1.47
1.40
1.1
1.1
2.68
6.73
u/ml
—
5
31
37
257
1.46
1.35
2.8
2.5
186.65
183.89
%
0.07
37
245
30
200
1.51
1.33
2.5
2.2
217.05
88.03
ug/min
0.31
11
116
19
113
1.69
1.32
2.0
2.3
2.77
5.03
umol/l
2.09
11
85
8
34
2.36
1.29
1.1
1.1
1417.00
1725.12
miu/ml
—
8
34
22
138
1.61
1.27
1.0
1.1
2.30
2.30
u/ml
—
10
65
9
45
2.01
1.23
1.1
1.1
—
—
—
0
0
5
19
2.64
1.21
2.4
1.6
111.40
77.79
nmol/24h
—
5
19
8
37
2.17
1.21
2.3
2.3
53.13
49.49
umol/l
—
8
30
45
332
1.37
1.20
2.2
2.2
14358.51
2603.76
u/l
0.50
15
130
24
157
1.54
1.18
7.1
3.7
56.63
57.92
%
0.14
24
157
13
72
1.82
1.15
1.9
1.3
22685.71
45716.44
e6/l
—
7
39
8
40
2.01
1.12
1.1
2.7
26.29
230.52
ug/l
—
8
33
15
88
1.71
1.11
1.7
2.3
57.44
26.77
mg/l
—
9
20
10
51
1.97
1.11
1.5
1.1
—
—
—
0
0
8
41
1.96
1.09
1.1
1.7
—
73.43
%
—
0
7
8
41
1.96
1.09
2.9
3.0
—
—
—
0
0
192
1698
1.16
1.07
2.8
2.8
0.73
0.74
ug/l
0.06
125
1079
16
97
1.66
1.07
2.8
2.3
—
—
—
0
0
12
68
1.77
1.00
1.5
1.6
—
—
—
0
0
21
140
1.51
0.98
1.5
1.2
5.20
3.76
u/ml
—
5
45
24
165
1.47
0.97
1.1
1.1
0.65
3.34
u/ml
1.72
11
81
6
29
2.07
0.89
1.7
1.7
105.00
55.66
ug/l
—
6
29
22
152
1.46
0.88
5.9
3.2
4.10
4.51
e9/l
0.43
22
152
15
97
1.55
0.81
2.3
2.3
32.87
33.26
pg
0.11
15
97
40
312
1.29
0.80
3.9
3.5
567.55
4573.88
u/ml
0.67
33
269
145
1293
1.14
0.75
1.4
1.4
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
—
—
—
0
0
12
76
1.59
0.72
2.6
1.6
16.92
20.36
nmol/l
1.52
12
70
5
26
1.93
0.70
1.8
3.5
—
—
—
0
0
5
26
1.93
0.70
1.8
3.5
—
—
—
0
0
18
126
1.44
0.70
1.3
1.2
—
—
—
0
0
20
143
1.41
0.70
1.1
1.0
1.76
2.03
u/ml
0.19
11
64
40
320
1.26
0.68
1.5
1.2
0.30
1.35
u/ml
—
5
23
7
44
1.59
0.65
1.1
1.1
—
—
—
0
0
5
29
1.73
0.64
1.4
1.1
119.60
107.39
%
—
5
23
32
252
1.28
0.63
1.9
2.0
—
—
—
0
0
28
217
1.30
0.62
1.3
1.4
—
—
—
0
0
5
30
1.67
0.61
2.0
1.4
7.41
8.60
ug/l
—
5
30
5
30
1.67
0.61
5.2
4.0
—
—
—
0
0
24
183
1.32
0.60
3.8
3.5
34.71
28.53
mg/l
0.23
19
117
8
53
1.51
0.58
1.0
1.1
—
43.20
—
0
5
100
888
1.14
0.58
1.9
1.7
—
—
—
0
0
6
35
1.72
0.57
1.0
1.0
—
—
—
0
0
8
54
1.49
0.57
1.0
1.1
—
61.88
—
0
8
8
54
1.49
0.57
1.5
1.1
—
—
—
0
0
23
297
0.77
0.57
1.3
1.4
—
—
—
0
0
19
142
1.34
0.54
1.6
1.2
11.22
5.77
u/ml
—
9
61
6
38
1.58
0.54
2.3
2.3
—
—
—
0
0
11
74
1.49
0.53
1.3
1.4
181.75
158.11
pmol/l
0.35
11
74
10
68
1.48
0.47
1.1
1.5
0.00
1.34
promille
—
5
55
7
49
1.43
0.46
1.3
1.4
8.16
7.59
u/l
—
7
41
17
129
1.32
0.46
1.3
1.1
115.00
113.96
%
0.04
17
118
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
11
79
1.40
0.41
1.1
1.1
—
—
—
0
0
69
616
1.13
0.41
1.2
1.2
196.18
152.05
iu/ml
0.28
23
249
8
60
1.34
0.40
1.0
1.0
—
—
—
0
0
5
35
1.43
0.39
1.0
1.8
—
—
—
0
0
40
347
1.16
0.36
1.8
1.9
—
—
—
0
0
13
168
0.77
0.36
2.0
1.6
—
—
—
0
0
10
73
1.37
0.34
1.2
1.4
—
—
—
0
0
26
219
1.19
0.33
1.3
1.2
—
1.82
—
0
9
7
53
1.32
0.31
1.3
1.2
—
—
—
0
0
7
53
1.32
0.31
1.3
1.7
1.57
5.37
u/field
—
7
39
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
8
65
1.23
0.27
1.4
1.2
—
—
—
0
0
15
123
1.22
0.25
1.5
1.6
—
—
—
0
0
10
78
1.28
0.24
3.8
3.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
0.01
—
0
6
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
66.45
—
0
12
11
89
1.24
0.21
1.2
1.1
—
—
—
0
0
40
364
1.10
0.20
1.8
1.9
5.75
3.30
mg/l
0.77
30
267
17
145
1.18
0.20
1.6
1.3
24.24
35.60
u/l
0.32
17
125
6
49
1.23
0.20
1.0
1.3
—
64.44
—
0
9
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
51
1.18
0.19
1.3
1.1
—
—
—
0
0
17
146
1.17
0.19
1.2
1.1
42.40
13.05
iu/ml
—
5
33
25
222
1.13
0.19
2.2
1.9
199.80
207.63
pmol/l
0.11
25
209
6
53
1.13
0.18
1.5
1.2
—
—
—
0
0
7
63
1.11
0.17
1.0
1.1
290.29
228.02
mg/l
—
7
56
11
92
1.20
0.16
1.2
1.1
—
—
—
0
0
16
140
1.15
0.15
1.3
1.1
—
—
—
0
0
27
295
0.91
0.14
1.5
1.4
—
—
—
0
0
9
108
0.83
0.13
1.0
1.1
—
—
—
0
0
40
427
0.93
0.13
1.6
1.5
—
—
—
0
0
24
219
1.10
0.12
1.8
1.9
2.34
5.35
iu/l
—
7
80
24
259
0.92
0.10
1.5
1.5
—
—
—
0
0
23
248
0.93
0.09
1.4
1.4
—
—
—
0
0
23
247
0.93
0.08
1.4
1.4
—
—
—
0
0
5
65
0.77
0.08
1.2
1.4
73.00
80.34
umol/l
—
5
65
7
64
1.09
0.08
1.4
1.2
—
—
—
0
0
7
64
1.09
0.08
1.4
1.2
—
—
—
0
0
100
974
1.03
0.08
5.0
4.3
31.69
31.56
%
0.04
77
679
16
150
1.07
0.04
1.5
1.4
—
—
—
0
0
12
111
1.08
0.04
1.0
1.1
—
—
—
0
0
20
208
0.96
0.02
1.4
1.3
—
—
—
0
0
24
248
0.97
0.02
1.4
1.4
—
—
—
0
0
24
248
0.97
0.02
1.4
1.4
—
—
—
0
0
20
202
0.99
0.00
1.5
1.5
—
—
—
0
0
11
115
0.96
0.00
1.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
9.7
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
5
52
0.96
0.00
1.0
1.4
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.1
—
1.05
—
0
18
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
49
1.02
-0.00
1.2
1.9
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CAMPYLOENTERITIS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CAMPYLOENTERITIS | 1.153 [0.98, 1.35] | 0.078 |
| Birth year | 0.995 [0.99, 1.0] | 0.213 |
During the follow-up period (1.1.1998 — 31.12.2019), 278 out of 2315 females with CAMPYLOENTERITIS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CAMPYLOENTERITIS | 1.03 [0.89, 1.19] | 0.694 |
| Birth year | 0.99 [0.98, 1.0] | 0.059 |
During the follow-up period (1.1.1998 — 31.12.2019), 344 out of 2843 males with CAMPYLOENTERITIS died.
Mortality risk
Mortality risk for people of age
years, who have CAMPYLOENTERITIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.103% | 0.225% |
| 5 | 0.704% | 1.39% |
| 10 | 1.658% | 3.461% |
| 15 | 3.356% | 6.371% |
| 20 | 5.84% | 10.663% |
Relationships between endpoints
↥Index endpoint: CAMPYLOENTERITIS – Campylobacter enteritis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data